Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Case Report



Management of Osteoarthritis through Blood letting therapy- A case report

Seetha Chandran, Biswajyothi Patgiri, Prakash Managalasseri, Prasanth Dharmarajan, Remya Elavana, Prasanth Bedarkar.

Abstract
Background: Osteoarthritis (OA) is the most common chronic condition of the joints characterised by deep achy pain, stiffness and reduced range of motion. OA can be correlated with Sadhigatavata in Ayurveda. But when it get affected with complications like synovium inflammation, Raktanubhandhatwa (blood vitiation) occurs and we can brought it under ‘kroshtukasheera’ which is a Vatashonitha vyadhi. In Ayurveda, primary treatment of choice for Vatashonitha is Snehana (oleation) and Raktamoksha (Blood letting). A case of OA was managed at the OPD level by means of blood letting therapy and found to be effective.
Case report: A treatment protocol was designed based on the signs and symptoms of the patient and administered. Snehana followed by Virechana (purgation) and Sha mana (pacification) was done initially. Later 4 sittings of Raktamoksha was done by modified Shringavacharana ie by cupping therapy, in two months duration.
Result & Conclusion: Blood letting therapy was found to be effective in managing the knee joint pain and associated dysfunction. Quality of life of the patient was improved, as he could walk in a pain-free environment. Patient of OA should be given a choice against pain management therapies like knee arthroscopy and arthroplasty. This can be achieved by proper evaluation of the therapies adapted here and reproducing the same in a larger group.

Key words: Blood letting;Cupping; Koshtukasheersha; Osteoarthritis; Shringavacharana; Vatashonita



Similar Articles

CircLphn3 protects the blood-brain barrier in traumatic brain injury.
Cheng YQ, Wu CR, Du MR, Zhou Q, Wu BY, Fu JY, Balawi E, Tan WL, Liao ZB
Neural regeneration research. 2022; 17(4): 812-818

Non-invasive gene delivery across the blood-brain barrier: present and future perspectives.
Kimura S, Harashima H
Neural regeneration research. 2022; 17(4): 785-787

Choice of ABO Group for Blood Component Transfusion in ABO-Incompatible Solid Organ Transplantation: A Questionnaire Survey in Korea and Guideline Proposal.
Chung Y, Ko DH, Lim J, Kim KH, Kim H
Annals of laboratory medicine. 2022; 42(1): 105-109

Use of Cocultures to Measure the Blood-Brain Barrier Permeability of Oxytocin.
Yamamoto Y, Harashima A, Munesue SI, Higashida H
Methods in molecular biology (Clifton, N.J.). 2022; 2384(): 247-255

A low dose cell therapy system for treating osteoarthritis: study and mechanistic investigations.
Wang B, Liu W, Li JJ, Chai S, Xing D, Yu H, Zhang Y, Yan W, Xu Z, Zhao B, Du Y, Jiang Q
Bioactive materials. 2022; 7(): 478-490


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.



ScopeMed Web Sites